Prevention of 7-ketocholesterol-induced side effects by natural compounds.


Journal

Critical reviews in food science and nutrition
ISSN: 1549-7852
Titre abrégé: Crit Rev Food Sci Nutr
Pays: United States
ID NLM: 8914818

Informations de publication

Date de publication:
2019
Historique:
pubmed: 12 7 2018
medline: 20 2 2020
entrez: 12 7 2018
Statut: ppublish

Résumé

Cholesterol oxidation products, also named oxysterols, can be formed either by cholesterol auto-oxidation, enzymatically or both. Among these oxysterols, 7-ketocholesterol (7KC) is mainly formed during radical attacks that take place on the carbon 7 of cholesterol. As increased levels of 7KC have been found in the tissues, plasma and/or cerebrospinal fluid of patients with major diseases, especially age-related diseases (cardiovascular diseases, eye diseases, neurodegenerative diseases), some cancers, and chronic inflammatory diseases, it is suspected that 7KC, could contribute to their development. Since 7KC, provided by the diet or endogenously formed, is not or little efficiently metabolized, except in hepatic cells, its cellular accumulation can trigger numerous side effects including oxidative stress, inflammation and cell death. To counteract 7KC-induced side effects, it is necessary to characterize the metabolic pathways activated by this oxysterol to identify potential targets for cytoprotection and geroprotection. Currently, several natural compounds (tocopherols, fatty acids, polyphenols, etc) or mixtures of compounds (oils) used in traditional medicine are able to inhibit the deleterious effects of 7KC. The different molecules identified could be valued in different ways (functional foods, recombinant molecules, theranostic) to prevent or treat diseases associated with 7KC.

Identifiants

pubmed: 29993272
doi: 10.1080/10408398.2018.1491828
doi:

Substances chimiques

Antioxidants 0
Fatty Acids 0
Ketocholesterols 0
Polyphenols 0
7-ketocholesterol O7676FE78M
Tocopherols R0ZB2556P8

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

3179-3198

Auteurs

Fatiha Brahmi (F)

Team 'Biochemistry of the Peroxisome, Inflammation and Lipid Metabolism', Lab. Bio-PeroxIL, Université de Bourgogne Franche-Comté, Dijon, France.
Lab. Biomathématique, Biochimie, Biophysique et Scientométrie, Faculté des Sciences de la Nature et de la Vie, Université de Bejaia, Bejaia, Algeria.

Anne Vejux (A)

Team 'Biochemistry of the Peroxisome, Inflammation and Lipid Metabolism', Lab. Bio-PeroxIL, Université de Bourgogne Franche-Comté, Dijon, France.

Randa Sghaier (R)

Team 'Biochemistry of the Peroxisome, Inflammation and Lipid Metabolism', Lab. Bio-PeroxIL, Université de Bourgogne Franche-Comté, Dijon, France.
Lab-NAFS 'Nutrition - Functional Food & Vascular Health', LR12ES05, Université de Monastir, Monastir, Tunisia.
Faculty of Medicine, Lab. Biochemistry, Sousse, Tunisia.

Amira Zarrouk (A)

Lab-NAFS 'Nutrition - Functional Food & Vascular Health', LR12ES05, Université de Monastir, Monastir, Tunisia.
Faculty of Medicine, Lab. Biochemistry, Sousse, Tunisia.

Thomas Nury (T)

Team 'Biochemistry of the Peroxisome, Inflammation and Lipid Metabolism', Lab. Bio-PeroxIL, Université de Bourgogne Franche-Comté, Dijon, France.

Wiem Meddeb (W)

Team 'Biochemistry of the Peroxisome, Inflammation and Lipid Metabolism', Lab. Bio-PeroxIL, Université de Bourgogne Franche-Comté, Dijon, France.
LMMA/IPEST, Faculty of Science, University of Carthage, Bizerte, Tunisia.

Leila Rezig (L)

Team 'Biochemistry of the Peroxisome, Inflammation and Lipid Metabolism', Lab. Bio-PeroxIL, Université de Bourgogne Franche-Comté, Dijon, France.
ESIAT, Lab. Conservation et Valorisation des Aliments, Tunis, Tunisia.

Amira Namsi (A)

Team 'Biochemistry of the Peroxisome, Inflammation and Lipid Metabolism', Lab. Bio-PeroxIL, Université de Bourgogne Franche-Comté, Dijon, France.
University Tunis El Manar, Faculty of Science of Tunis, Laboratory of Functional Neurophysiology and Pathology, Tunis, Tunisia.

Khouloud Sassi (K)

Team 'Biochemistry of the Peroxisome, Inflammation and Lipid Metabolism', Lab. Bio-PeroxIL, Université de Bourgogne Franche-Comté, Dijon, France.
Lab. Onco-Hematology, Faculty de Medicine of Tunis, Université de Tunis El Manar, Tunis, Tunisia.

Aline Yammine (A)

Team 'Biochemistry of the Peroxisome, Inflammation and Lipid Metabolism', Lab. Bio-PeroxIL, Université de Bourgogne Franche-Comté, Dijon, France.
Bioactive Molecules Research Lab, Faculty of Sciences, Lebanese University, Beirut, Lebanon.

Iham Badreddine (I)

Team 'Biochemistry of the Peroxisome, Inflammation and Lipid Metabolism', Lab. Bio-PeroxIL, Université de Bourgogne Franche-Comté, Dijon, France.
Lab. 'Valorisation des Ressources Naturelles et Environnement', Université Ibn Zohr, Taroudant, Morocco.

Dominique Vervandier-Fasseur (D)

Institut of Molecular Chemistry (ICMUB UMR 6302), Université Bourgone Franche-Comté, Dijon, France.

Khodir Madani (K)

Lab. Biomathématique, Biochimie, Biophysique et Scientométrie, Faculté des Sciences de la Nature et de la Vie, Université de Bejaia, Bejaia, Algeria.

Lila Boulekbache-Makhlouf (L)

Lab. Biomathématique, Biochimie, Biophysique et Scientométrie, Faculté des Sciences de la Nature et de la Vie, Université de Bejaia, Bejaia, Algeria.

Boubker Nasser (B)

Lab. Neuroscience and Biochemistry, Université Hassan 1er, Settat, Morocco.

Gérard Lizard (G)

Team 'Biochemistry of the Peroxisome, Inflammation and Lipid Metabolism', Lab. Bio-PeroxIL, Université de Bourgogne Franche-Comté, Dijon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH